Add to Favorites Newsroom RSS Share
New Haven, CT USA

Our News on Newswise

Lower Thyroid Stimulating Hormone Levels Elevate Risk of Thyroid Cancer, Yale Study Finds

thyroid.jpg

There is an increased risk of thyroid cancer associated with lower-than-normal thyroid hormone levels, a finding that could have a major impact on patients fighting the disease.
18-Sep-2017 2:05 PM EDT Add to Favorites

Scientists See Progress for Cancer Vaccines

Sznol2.jpg

Tumor-destroying vaccines have emerged as a new weapon in the fight against cancer.
18-Sep-2017 2:05 PM EDT Add to Favorites

Yale Study: Earlier Hospice Care Would Improve Quality of End of Life

hospice.jpg

Older, terminally ill patients could improve the quality of their last days by accessing hospice services much sooner, according to a Yale School of Medicine-led study.
18-Sep-2017 2:05 PM EDT Add to Favorites

Multigene Test May Help Identify Hereditary Kidney Cancers

ShuchClinical_1.jpg

A multigene panel test could be a useful diagnostic tool to help clinicians identify patients with a hereditary kidney cancer syndrome, according to the results of a study published in Cancer.
13-Sep-2017 12:55 PM EDT Add to Favorites

Limiting Surgeries for Small Kidney Tumors

ShuchClinical.jpg

Not all kidney cancers are killers, and many small tumors can be left alone or watched over time because there is a low risk they will become dangerous, according to Dr. Brian Shuch at the Yale School of Medicine.
13-Sep-2017 10:05 AM EDT Add to Favorites

Ramucirumab plus Docetaxel Improves Progression-free survival in Urothelial Cancer

petrylak.png

Ramucirumab plus docetaxel improves progression-free survival in patients with advanced or metastatic urothelial cancer who have progressed on platinum-based chemotherapy, according to late-breaking results from the phase III RANGE trial presented...
13-Sep-2017 10:05 AM EDT Add to Favorites

Dr. Peter Glazer Receives Prestigious Outstanding Investigator Award for Cancer Research

PeterGlazerMDPhD.jpg

The National Cancer Institute (NCI) has named Peter M. Glazer, M.D., Ph.D., as a recipient of its Outstanding Investigator Award (OIA).
1-Sep-2017 11:05 AM EDT Add to Favorites

Study Pinpoints Gene’s New Role in Pancreatic Cancer

pancreas.jpg

Pancreatic cancer is a particularly deadly form of disease, and patients have few options for effective treatment. But a new Yale Cancer Center study has identified a gene that is critical to pancreatic cancer cell growth, revealing a fresh target...
14-Aug-2017 11:05 AM EDT Add to Favorites

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact member@newswise.com to configure this module.




Chat now!